Skip to main content
SpringerLink
Log in

The effects of bicarbonate and acetate haemodialysis on platelet cyclic AMP concentration, thromboxane B2 release and aggregation

  • Original Article
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

Abstract

The effects of chronic uraemia and serial acetate (HDA) or bicarbonate (HDB) hacmodialysis on the aggregation, thromboxane B2 (TXB2) release and cyclic AMP (cAMP) concentration of platelets from arterial blood were studied in 14 uraemic patients (6 dialysed and 8 conservatively treated) and 10 controls. Platelets from uraemic patients, either dialysed or treated conservatively, exhibited a significantly higher cAMP level (P<0.005), a lower TXB2 level (P<0.01), and a lower aggregability (P<0.001) than the controls. The platelet cAMP level was more markedly decreased after HDB than after HDA (P<0.05). Greater increases in platelet aggregation (P<0.05) and TXB2 formation were observed after HDB than after HDA. The concentration of platelet cAMP and aggregability, and also the platelet cAMP and the TXB2 level showed a significantly negative correlation (r=−0.7,P<0.05 andr=−0.60,P<0.05, respectively). There was a positive correlation between the platelet-derived TXB2 and the aggregability (r=0.67,P<0.05). Although most patients had secondary hyperparathyroidism, the serum parathyroid hormone level did not correlate closely with the cAMP, TXB2 or aggregation results. The dysfunction of uraemic platelets accompanied by a reduced TXB2 release may be explained by an increased cAMP and a decreased arachidonic acid availability. HDB improves the platelet function to a greater degree than does HDA.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Larsson SO, Hedner U, Nilsson IM (1971) On coagulation and fibrinolysis in conservatively treated chronic uraemia. Acta Med Scand 189: 433–441

    PubMed  Google Scholar 

  2. Larsson SO, Hedner U, Nilsson IM (1971) On coagulation and fibrinolysis in uraemic patients on maintenance haemodialysis. Acta Med Scand 189: 443–451

    PubMed  Google Scholar 

  3. Eknoyan G, Wacksman SJ, Glueck H, Will JJ (1969) Platelet function in renal failure. N Engl J Med 280: 677–681

    PubMed  Google Scholar 

  4. Weis HJ, Eichelberger JW (1968) Secondary thrombocytopathy: platelet factor-3 in various disease states. Arch Intern Med 47: 901–905

    Google Scholar 

  5. Rabiner SF, Hrodeck O (1968) Platelet factor-3 in normal subjects and patients with renal failure. J Clin Invest 47: 901–912

    PubMed  Google Scholar 

  6. Lewis JH, Zucker MB, Ferguson JH (1956) Bleeding tendency in uraemia. Blood 11: 1073–1076

    PubMed  Google Scholar 

  7. O'Grady JA (1959) Bleeding tendency in uraemia. JAMA 169: 1727–1732

    Google Scholar 

  8. Remuzzi G, Livio M, Marchiaro G, Mecca G, De Gaetano G (1978) Bleeding in renal failure. Altered platelet function in chronic uraemia only partially corrected by haemodialysis. Nephron 22: 347–353

    PubMed  Google Scholar 

  9. Steiner RW, Coggins C, Carvalho ACA (1979) Bleeding time in uraemia: a useful test to assess clinical bleeding. Am J Hematol 7: 107–117

    PubMed  Google Scholar 

  10. Lindsay RM, Friesen M, Koens F, Linton AL, Oreopulos D, De Veber G (1976) Platelet function in patients on long term peritoneal dialysis. Clin Nephrol 6: 335–339

    PubMed  Google Scholar 

  11. Rabiner SF, Molinas F (1970) The role of phenol and phenolic acid on the thrombocytopathy and defective platelet aggregation of patients with renal failure. Am J Med 49: 346–351

    PubMed  Google Scholar 

  12. Horowitz HI, Stein IM, Cohen BD, White JG (1970) Further studies on the platelet-inhibiting effect of guanidinsuccinic acid and its role in uremic bleeding. Am J Med 49: 336–340

    PubMed  Google Scholar 

  13. WoodsHF, Ash G, Parsons V, Weston MJ (1979) Reduction of dialyser fibrin deposition with sulphinpyrazone. Clin Nephrol 12: 122–126

    PubMed  Google Scholar 

  14. Di Minno G, Martinez J, McKean M, De la Rosa J, Burke JF, Murphy S (1985) Platelet dysfunction in uremia. Multifaceted defect partially corrected by dialysis. Am J Med 79: 552–558

    PubMed  Google Scholar 

  15. Vlacoyannis J, Schoeppe W (1982) Adenylate cyclase activity and cAMP content in human platelets in uraemia. Eur J Clin Invest 12: 379–381

    PubMed  Google Scholar 

  16. Livio M, Benigni A, Remuzzi G (1985) Coagulation abnormalities in uremia. Semin Nephrol 5: 82–90

    PubMed  Google Scholar 

  17. Docci D, Turci F, Delvecchio C, Gollini C, Baldrati L, Pistocchi E (1986) Lack of evidence for the role of secondary hyperparathyroidism in the pathogenesis of uremic thrombocytopathy. Nephron 43: 28–32

    PubMed  Google Scholar 

  18. Defreyn G, Vergasa Dauden M, Machin SJ, Vermylen J (1980) A plasma factor in uraemia which stimulates prostacyclin release from cultured endothelial cells. Thromb Res 19: 695–699

    PubMed  Google Scholar 

  19. Moncada S (1980) Prostacyclin and thromboxane A2 in the regulation of platelet-vascular interactions. In: Remuzzi G, Mecca G, Gaetano G de (eds) Hemostasis, prostaglandins and renal disease. Raven Press, New York, p 175

    Google Scholar 

  20. Furakawa H, Bilezikian JP, Loeb JN (1980) Effects of ouabain and isoproterenol on potassium influx in the turkey erythrocyte. Quantitative relation to ligand binding and cyclic AMP generation. Biochim Biophys Acta 598: 345–356

    PubMed  Google Scholar 

  21. Granstrom E, Kindahl H (1978) Radio-immunoassay for prostaglandins and thromboxanes. In: Frolich JC (ed) Advances in prostaglandin and thromboxane research. Raven Press, New York, p 119

    Google Scholar 

  22. Castaldi PA, Sydney MB (1966) The bleeding disorder of uraemia. A qualitative platelet defect. Lancet II: 66–69

    Google Scholar 

  23. Evans EP, Brauch RA, Bloom AL (1972) A clinical and experimental study of platelet function in chronic renal failure. J Clin Pathol 25: 745–753

    PubMed  Google Scholar 

  24. Stewart JH, Castaldi PA (1967) Uraemic bleeding: a reversible platelet defect corrected by dialysis. Q J Med 36: 409–423

    PubMed  Google Scholar 

  25. Rabiner SF (1972) The effect of dialysis on platelet function of patients with renal failure. Ann NY Acad Sci 201: 234–242

    PubMed  Google Scholar 

  26. Remuzzi G, Pusineri F (1988) Coagulation defects in uremia. Kidney Int 33 [Suppl 24]: 13–17

    Google Scholar 

  27. Remuzzi G, Pusineri F (1989) The uraemic platelet. In: Remuzzi G, Rossi EC (eds) Haemostasis and the kidney. Butterworths, London, p 107

    Google Scholar 

  28. Lehninger AL (1978) Biochemistry, 2nd edn. Worth, New York, pp 519–520

    Google Scholar 

  29. Aviram M, Brook JG, Lees AM, Lees RS (1981) Low density lipoprotein binding to human platelets. Role of charge and specific amino acid. Biochem Biophys Res Commun 99: 308–318

    PubMed  Google Scholar 

  30. Koller E, Koller F, Doleschel W (1982) Specific binding sites on human blood platelets for plasma lipoproteins. Hoppe-Seyler's Z Zool Physiol Chem Biol 363: 395–405

    Google Scholar 

  31. Bjomson J (1978) Thrombus formation in the artificial kidney. Scand J Urol Nephrol 12: 251–257

    PubMed  Google Scholar 

  32. Zucker MB (1979) Biological aspects of heparin action. Heparin and platelet function. Fed Proc 36: 47–49

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Paediatrics, Albert Szent-Györgyi Medical University, 14 Korányi Str., Szeged, Hungary

    Sándor Túri, Csaba Bereczki & Zoltán Havass

  2. Department of Experimental Surgery, Albert Szent-Györgyi Medical University, 14 Korányi Str., Szeged, Hungary

    Csilla Torday

  3. Department of Clinical Chemistry, Albert Szent-Györgyi Medical University, 14 Korányi Str., Szeged, Hungary

    Márta Németh

Authors
  1. Sándor Túri
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Csaba Bereczki
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Csilla Torday
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Zoltán Havass
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Márta Németh
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Túri, S., Bereczki, C., Torday, C. et al. The effects of bicarbonate and acetate haemodialysis on platelet cyclic AMP concentration, thromboxane B2 release and aggregation. Pediatr Nephrol 5, 327–331 (1991). https://doi.org/10.1007/BF00867493

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00867493

Key words

Search

Navigation